Eli Lilly
LLY
NYSE
Pharma
Markets openAuto-updating · last checked
Global pharmaceutical major with a growing neuroscience and metabolic portfolio.
12-month trend
Fundamentals
Revenue, earnings and balance-sheet data for LLY, updated as each quarter is reported.
Recent news
- Lilly wants to study and improve the psychedelic ibogaine, its neuro leader saysendpoints.news
- eli lilly new drug for weight loss - Olhar Digitalolhardigital.com.br
- eli lilly drug trials show record breaking weight loss results - Olhar Digitalolhardigital.com.br
- A Takeda spinout builds case for its Parkinson's drug | BioPharma Divebiopharmadive.com
- The next Ozempic might fix marriages｜My First Million - BigGo Financefinance.biggo.com
- ️ Eli Lilly's mind-blowing investment - Healthcare Brewhealthcare-brew.com
- Psychedelic Policy Briefing: Week of July 20th, 2026PSA News